Cite
MLA Citation
P Harter et al.. “Phase III PAOLA-1/ENGOT-ov25 trial: olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer treated with platinum-based chemotherapy plus bevacizumab.” International journal of gynecological cancer, vol. 29, n.d., pp. A10–A11. http://access.bl.uk/ark:/81055/vdc_100144729648.0x00001e